Program Profile
Last updated from Global Health Progress: 02 Sept 2020

Blueprint for Innovative Healthcare Access – Meru County, Kenya

The Blueprint for Innovative Healthcare Access is a proven partnership model, focused on delivery and implementation, and applied in a targeted and measurable way to save and improve the lives of patients with cancer and other Non Communicable Diseases (NCDs) – through earlier diagnosis and local access to consistent high-quality treatment and innovative medicines.

The Blueprint for Innovative Healthcare Access is designed to sustainably strengthen healthcare systems at a local level by building a consortium of partners (private sector, governments, Non-Governmental Organisations (NGOs), healthcare professionals and communities) who own and drive delivery at every stage of the patient journey – from awareness and prevention, screening, diagnosis, treatment and ongoing patient support, with faster integrated referrals. All of whom come together and work collaboratively as follows:

Fully understand the local healthcare environment and identifying the specific challenges or healthcare gaps in each therapeutic area or country.

Promote public awareness and education for prevention screening, early detection and treatment through customized campaigns that also address misconceptions and false information

Deliver culturally appropriate and customized training programs to increase earlier diagnosis, improve referrals and deliver high quality and consistent local clinical care and ongoing patient support services. This includes using engaging content and innovative digital platforms, mentoring and training of trainers for healthcare providers – from community volunteers, primary healthcare nurses and physicians, through to clinical specialists.

Deliver mass screenings for NCDs with timely diagnostic follow-up, including biopsies, radiology (CT scans, X-rays), blood pressure and blood glucose level measurement and ensures the consistent provision of medicines through a digitized stock and supply chain management system, including funding drugs during periods of stockouts.

Provide treatment and addressing affordability barriers including enrolling patients onto local healthcare insurance provisions and working with pharmaceutical companies on treatment financing mechanisms

Ensure robust data collection, and consistent, transparent and independent measurement to evaluate impact on the lives of patients and to hold all partners accountable. It also ensures NCD surveillance through analysis and reporting – enabling control management of cancer and other NCDs, and the establishment of global best-practice registries.

Ensure strong governance, leadership and co-ordination to effectively implement, manage and sustain the project.

Meru County in Kenya was selected as the Blueprint pilot county, launched in 2019 and led by Amref Health Africa, International Cancer Institute (ICI) and Takeda, together with local and regional partners to improve the lives of patients by strengthening the healthcare system for NCDs in the county and surrounding regions.

The data for this program has been reviewed by both the companies and the Access Observatory team.